Mark Dybul
2021
In 2021, Mark Dybul earned a total compensation of $430K as Chief Executive Officer at Enochian Biosciences, a 66% decrease compared to previous year.
Compensation breakdown
| Salary | $430,000 |
|---|---|
| Total | $430,000 |
Dybul received $430K in salary, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Mark Dybul's compensation ranked 11,028th out of 12,406 executives tracked by ExecPay. In other words, Dybul earned more than 11.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,028 out of 12,406 | 11th |
Division Manufacturing | 4,860 out of 5,492 | 12th |
Major group Chemicals And Allied Products | 2,170 out of 2,368 | 8th |
Industry group Drugs | 1,931 out of 2,089 | 8th |
Industry Pharmaceutical Preparations | 1,427 out of 1,536 | 7th |
Source: SEC filing on January 27, 2022.
Dybul's colleagues
We found one more compensation record of an executive who worked with Mark Dybul at Enochian Biosciences in 2021.
2021
Luisa Puche
Enochian Biosciences